Ist salicyloyl phytosphingosine in der Schwangerschaft sicher?
No harmonised CLP classification, no SCCS or CIR reproductive safety assessment located, and no animal or human reproductive/teratology data were identified for salicyloyl phytosphingosine; published literature describes topical skin effects (procollagen, barrier repair) but not reproductive toxicity. The ingredient is a cosmetic sphingolipid derivative used at low % in topical products, so systemic exposure from normal cosmetic use is expected to be low but measurable. Sources: PubMed (dermatology/skin studies), PubChem/Chemical databases, EWG entry. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/18489360/))
Pregnancy-safe products containing salicyloyl phytosphingosine










Related ingredients
Frequently asked questions
- Ist salicyloyl phytosphingosine in der Schwangerschaft sicher?
- No harmonised CLP classification, no SCCS or CIR reproductive safety assessment located, and no animal or human reproductive/teratology data were identified for salicyloyl phytosphingosine; published literature describes topical skin effects (procollagen, barrier repair) but not reproductive toxicity. The ingredient is a cosmetic sphingolipid derivative used at low % in topical products, so systemic exposure from normal cosmetic use is expected to be low but measurable. Sources: PubMed (dermatology/skin studies), PubChem/Chemical databases, EWG entry. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/18489360/))
- Ist salicyloyl phytosphingosine während des Stillens sicher?
- No data on transfer into breast milk or breastfeeding-associated studies were found; with no reproductive or developmental toxicity signals and low expected systemic absorption from topical cosmetics, hazard is not indicated. Exposure is considered low but measurable as for pregnancy. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/18489360/))
- Ist salicyloyl phytosphingosine sicher für Babyhaut?
- No infant‑specific toxicity data were identified. Following the user's scoring rules, because the ingredient has measurable (though low) dermal exposure in adults (see above) baby exposure is increased by +1 due to immature barrier and higher surface‑area‑to‑weight; there are still no data suggesting developmental/dermal hazard for infants. The literature describes topical skin benefits (barrier repair, anti‑inflammatory) rather than harm. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/18489360/))
- Wie bewertet VeriMom salicyloyl phytosphingosine?
- VeriMom bewertet salicyloyl phytosphingosine mit 93/100 (keine bekannten Risiken) basierend auf EU CosIng, ECHA-Klassifizierungen und PubMed-Studien.
- Was sind schwangerschaftssichere Alternativen zu salicyloyl phytosphingosine?
- Siehe unsere kuratierte Liste der schwangerschaftssicheren Alternativen zu salicyloyl phytosphingosine basierend auf ähnlicher Funktion.
Prüfe jede Zutatenliste in 2 Sekunden
Lade VeriMom kostenlos — scanne jedes Produkt und sieh sofort die Schwangerschafts-Sicherheitsbewertung.
Medizinischer Haftungsausschluss
Diese Informationen dienen ausschließlich Bildungszwecken und stellen keine medizinische Beratung dar. Sicherheitsbewertungen basieren auf öffentlich zugänglichen Daten und spiegeln möglicherweise nicht alle Risiken wider. Konsultieren Sie immer Ihren Arzt, bevor Sie ein Produkt während der Schwangerschaft oder Stillzeit verwenden.